[S]erious problems in single-payer systems in Europe and Canada have been well documented. Innovative new drugs in Europe, for instance, take far longer to reach the public than they do in the United States — six months longer for cancer drugs and up to 24 months for other medicines.Agreed--American healthcare needs more, not less, competition.
A 2007 Frasier Institute study showed delays in Canada are even worse, and thousands of Canadians head south to the United States when they need care quickly. In Great Britain, stories are legion about months-long waits for life-saving surgeries. And in July of last year, the Daily Mail featured a story on a 108-year-old woman who was told she must wait 18 months for a new hearing aid.
Conversely, when consumers choose their doctors and health care insurance from among private doctors and companies, costs and access improve because providers must satisfy patients, not bureaucrats. The otherwise-problematic Medicare prescription drug program, for instance, at least requires private insurance companies to compete for patient participation. Result: In the first two years, average premium costs were less than $24 per month, far better than the $37 predicted by Congress.
(via Conservative Grapevine)